Assessment of Quality of Life and Therapeutic Outcomes of Metformin, Pioglitazone with Myoinositol and Ethinylestradiol Cyproterone in Ethnic Pakistani Women with Polycystic Ovary Syndrome
January 2019
Studysummary In this study, metformin, pioglitazone, and ethinylestradiol cyproterone all improved various clinical features and quality of life in Pakistani women with PCOS, though no drug significantly reduced hirsutism.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on reproductive-endocrinology-infertility.imedpub.com →